Clik here to view.
犹他大学Huntsman癌症研究所为犹他州首家质子治疗中心选用Mevion的紧凑型单室系统
马萨诸塞州利特尔顿 (美国商业资讯)–Mevion Medical System宣布，犹他大学(U of U) Huntsman癌症研究所(HCI)已签署合同，采购一台装备HYPERSCAN Pencil Beam ScanningTM (PBS)技术的MEVION S250i Proton Therapy System™。 本新闻稿包含多媒体。此处查看新闻稿全文：...
View ArticleClik here to view.
Sinovac Comments on Unauthorized Use of Falsified Sinovac Hong Kong’s Company...
BEIJING Sinovac Biotech Ltd. (NASDAQ: SVA) (“Sinovac” or the “Company”), became aware Monday October 8, 2018 that unauthorized changes have been made to the Hong Kong Companies Registry for Sinovac...
View ArticleClik here to view.
Celltrion and Teva Announce FDA Oncologic Drugs Advisory Committee Recommends...
SILVER SPRING, Md. & JERUSALEM Celltrion, Inc. (KRX:068270) and Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced the U.S. Food and Drug Administration (FDA) Oncologic...
View ArticleClik here to view.
WellSky and Digi-Trax Partner to Power Safer and More Efficient Cellular...
LENEXA, Kan. WellSky, a leading health and community care technology company backed by TPG Capital, and Digi-Trax Corporation, a global leader in compliance labeling solutions, have formed an...
View ArticleClik here to view.
Semtech and SK Telecom Leverage LoRa Technology to Monitor Cattle Health
CAMARILLO, Calif. Semtech Corporation (Nasdaq: SMTC), a leading supplier of high performance analog and mixed-signal semiconductors and advanced algorithms, announced that SK Telecom, one of South...
View ArticleClik here to view.
Evecxia Licenses Additional IP from NUS, NUH and NTU in Singapore
RESEARCH TRIANGLE PARK, N.C. Evecxia, Inc., a privately funded, clinical stage biopharmaceutical company, today announced that it has licensed exclusive, world-wide rights to develop and...
View ArticleClik here to view.
德累斯顿心脏中心成为Imricor的首家商业化临床单位
明尼阿波利斯 (美国商业资讯) — Imricor今天宣布，该公司与德国德累斯顿心脏中心签署Advantage-MR EP记录仪/刺激仪系统并支持Vision-MR器械1的首份商业化合同。该协议将德累斯顿心脏中心置于MRI引导心脏消融临床进展的前沿，使该医院成为成长中的介入心脏磁共振(iCMR)领域的全球领导者。 本新闻稿包含多媒体。此处查看新闻稿全文：...
View ArticleClik here to view.
Dr. Reddy’s Laboratories Announces the Sale of Its API Manufacturing Business...
HYDERABAD, India Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, along with its subsidiaries together referred to as “Dr. Reddy’s”) today announced that it has entered into a...
View ArticleClik here to view.
Innovus Pharma Receives Approval from Amazon® to Expand its Amazon® Stores to...
SAN DIEGO Innovus Pharmaceuticals, Inc. (“Innovus Pharma” or the “Company”) (OTCQB Venture Market: INNV), an emerging commercial-stage pharmaceutical company that delivers safe, innovative and...
View ArticleClik here to view.
Dr. Reddy’s Laboratories Receives Approval for Aspirin and Extended-Release...
HYDERABAD, India & PRINCETON, N.J. Dr. Reddy’s Laboratories Ltd (BSE: 500124, NSE: DRREDDY, NYSE: RDY, along with its subsidiaries together referred to as “Dr. Reddy’s”) today announced receipt...
View ArticleClik here to view.
HiFiBiO Therapeutics Acquires H-Immune Therapeutics
CAMBRIDGE, Mass. & PARIS & SHANGHAI HiFiBiO Therapeutics, a world leader in the discovery of therapeutic antibodies through single-cell screening and analysis, announced today the...
View ArticleClik here to view.
Clik here to view.
Sinovac Commences Legal Proceedings to Nullify Filings Bearing a Falsified...
BEIJING Senior management of Sinovac Biotech Ltd. (NASDAQ: SVA) (“Sinovac” or the “Company”) and the lawful directors of Sinovac Hong Kong have commenced legal proceedings in the High Court of the...
View ArticleClik here to view.
Biogen and Samsung Bioepis Announce European Launch of IMRALDI™(adalimumab),...
CAMBRIDGE, Mass. & INCHEON, Korea Biogen (Nasdaq:BIIB) and Samsung Bioepis Co., Ltd. today announced the European launch of IMRALDI™ (adalimumab), a biosimilar referencing HUMIRA®. Starting...
View ArticleClik here to view.
Foundation Medicine Announces Strategic Collaboration with Major...
CAMBRIDGE, Mass. Foundation Medicine, Inc. today announced a strategic collaboration with Novartis allowing the development of companion diagnostic (CDx) tests for the Novartis portfolio of targeted...
View ArticleClik here to view.
レスメド初の最小接触面フルフェイスCPAPマスクAirFit F30を米国とカナダで販売開始
サンディエゴ （ビジネスワイヤ） — レスメド（NYSE: RMD、ASX: RMD）は本日、当社初の最小接触面フルフェイスCPAPマスクとなるAirFit F30を発売したと発表しました。AirFit F30は、睡眠時無呼吸症の患者が顔の擦れ跡を低減し、ベッドで眼鏡をかけ、ベッドパートナーのより近くでうずくまれるAirFitマスクポートフォリオの最新製品です。...
View ArticleClik here to view.
AVITA Medical Announces First U.S. Sales of RECELL® System and Commencement...
VALENCIA, Calif. & MELBOURNE, Australia AVITA Medical (ASX: AVH, OTCQX: AVMXY), a global regenerative medicine company, today announced that it has received the first commercial sales orders...
View ArticleClik here to view.
瑞思迈首款最小接触型全脸CPAP面罩AirFit F30现已在美国和加拿大发售
圣迭戈 (美国商业资讯) — 瑞思迈(ResMed, NYSE: RMD, ASX: RMD)今天宣布其首款最小接触型全脸CPAP面罩AirFit F30发售，这是其AirFit面罩阵容最新添加的成员，可帮助睡眠呼吸暂停患者减少脸部印痕、在床上佩戴眼镜、以及与同床伴侣更亲密地偎依。 本新闻稿包含多媒体。此处查看新闻稿全文：...
View ArticleClik here to view.
Takeda Receives Clearance from the Japan Fair Trade Commission for the...
OSAKA, Japan NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH...
View ArticleClik here to view.
Takeda to Present Results from Phase 3 ALTA-1L Trial Highlighting...
CAMBRIDGE, Mass. & OSAKA, Japan Takeda Pharmaceutical Company Limited (TSE: 4502) today announced that intracranial efficacy data from the Phase 3 ALTA-1L (ALK in Lung Cancer Trial of BrigAtinib...
View Article